These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10418760)

  • 21. Increasing prevalence of antimicrobial resistance among organisms isolated from blood culture in a Singapore hospital.
    Kumarasinghe G; Chow C; Yin LH; Hong SY; Bassett DC
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):116-22. PubMed ID: 7825001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of antimicrobial susceptibility of urinary pathogens in a tertiary care hospital.
    Arya SC; Agarwal N; Agarwal S
    Singapore Med J; 2007 Mar; 48(3):270-1; author reply 271. PubMed ID: 17342301
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.
    Jones RN
    Am J Med; 1996 Jun; 100(6A):3S-12S. PubMed ID: 8678095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial resistance surveillance in urinary tract infections in primary care.
    Chin TL; McNulty C; Beck C; MacGowan A
    J Antimicrob Chemother; 2016 Oct; 71(10):2723-8. PubMed ID: 27353470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problem pathogens in nosocomial infections of urinary tract.
    Resnick MI
    Urology; 1985 Jul; 26(1 Suppl):5-7. PubMed ID: 3892855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic resistance: current data from around the world and Tunisia].
    Ben Redjeb S
    Tunis Med; 1999 Oct; 77(10):472-7. PubMed ID: 10670277
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hospital-acquired urinary tract infections].
    Adukauskiene D; Cicinskaite I; Vitkauskiene A; Macas A; Tamosiūnas R; Kinderyte A
    Medicina (Kaunas); 2006; 42(12):957-64. PubMed ID: 17211103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial drug resistant pathogens in nosocomial urinary tract infections--selected aspects].
    Kamińska W; Dzierzanowska D
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():25-32. PubMed ID: 15669199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological factors influencing the emergence of antimicrobial resistance.
    Cohen ML
    Ciba Found Symp; 1997; 207():223-31; discussion 231-7. PubMed ID: 9189644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of global surveillance in combating bacterial resistance.
    Marchese A; Schito GC
    Drugs; 2001; 61(2):167-73. PubMed ID: 11270935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combating antimicrobial resistance and healthcare-associated infections: the role of the Specialist Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI), 2007-2011. Preface.
    Lord Soulsby of Swaffham Prior
    J Antimicrob Chemother; 2012 Jul; 67 Suppl 1():i1. PubMed ID: 23029664
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary tract infection. Diabetics and non-diabetic patients.
    Akbar DH
    Saudi Med J; 2001 Apr; 22(4):326-9. PubMed ID: 11331489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I].
    Sidorenko SV; Ivanov DV
    Antibiot Khimioter; 2005; 50(1):3-10. PubMed ID: 16302640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of appropriate antibiotic use.
    Niederman MS
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 3():S170-5. PubMed ID: 16543079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.